生物活性 | |||
---|---|---|---|
描述 | Cefpirome Sulfate (CPR) is an injectable extended-spectrum or 'fourth generation' cephalosporin. Its antibacterial activity encompasses many of the pathogens involved in hospital-acquired infections such as enterobacteriaceae, methicillin-susceptible staphylococcus aureus, coagulase-negative staphylococci and viridans group streptococci. The tolerability of cefpirome appears similar to that of ceftazidime and other third generation cephalosporins, diarrhoea being the most frequently observed event[3]. Cefpirome sulfate caused strong quenching of the fluorescence of lysozyme by a static quenching mechanism[4]. When cefpirome sulfate was injected intracutaneously at a high concentration of 20%, its irritating effects were only equal to or slightly stronger than those of distilled water for injection and Na2SO4 solution[5]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.63mL 0.33mL 0.16mL |
8.16mL 1.63mL 0.82mL |
16.32mL 3.26mL 1.63mL |
参考文献 |
---|
[5]Satoh R, Yajima R, Morioka H, et al. J Toxicol Sci. 1990;15 Suppl 3:147–171 |